International consortium validates non invasive tests for progressive liver disease
Two international studies show that non invasive blood and imaging tests can accurately detect and stage metabolic liver disease without requiring a biopsy.
FTMQ Health, written by our newsroom0 views
Two major international studies from the Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) consortium have validated non invasive diagnostic tests for liver disease, Bioengineer.org reported. The research established comprehensive prospective benchmarks for evaluating how accurately routine and advanced blood and imaging tests can detect and stage metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH). [1]
According to Bioengineer.org, the coordinated research efforts evaluated dozens of biomarkers against histological analysis from liver biopsies read by expert pathologists. A medical test is a procedure performed in a clinical setting to detect, diagnose, or monitor diseases, using diagnostic imaging, cellular analysis, or chemical testing. [1][3]
Liver disease, also known as hepatic disease, refers to any condition affecting the liver, which is termed chronic liver disease when it is long-lasting, according to background information. The dual studies evaluated non invasive methods specifically to monitor MASLD and MASH, establishing accurate benchmarks for medical diagnostics. [1][4]
In short
- Two major international studies from the LITMUS consortium validated non invasive tests for MASLD and MASH.
- The research evaluated dozens of routine and advanced biomarkers against expert-analyzed liver biopsies.
- The studies established prospective accuracy benchmarks for blood and imaging diagnostic tests.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]International LITMUS Studies Validate Non-Invasive Diagnostic Tests for Liver DiseaseBioengineer.org, 5d ago (the report this story comes from)
Background
- [2]Dobbs v. Jackson Women's Health Organization on Wikipedia
- [3]Medical test on Wikipedia
- [4]Liver disease on Wikipedia
Our newsroom writes these reports with the help of software, from the 4 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- Enzyme UBE2N May Help Stop Fatty Liver Disease ProgressionFitness, 44d ago
- Exercise types show similar benefits for chronic disease health indicatorsTop Stories, 6d ago
- Phase III breast cancer study tests reduced post surgery therapyMedical Science, 21d ago
More in Medical Science
- CAR T cell therapy analysis reveals high inflammation but low mortality5h ago
- Diets rich in dairy and fruit linked to child height growth1d ago
- Meningococcal B vaccine prompts immune responses against gonorrhea in trial2d ago
- RIPK1 Inhibitors Match Placebo Safety in Human Clinical Trials2d ago
- Frontiers in Psychiatry collection highlights music interventions for mental health3d ago
- Shanghai dismisses researchers after gene editing trial death3d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.